Please Wait.....
Report
mRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029
Market Report I 2025-03-01 I 351 Pages I MarketsandMarkets
The mRNA synthesis and manufacturing market is expected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024, at a CAGR of 3.4% during the forecast period. mRNA therapeutics hold promise as the next generation of drugs for tissue restoration in regenerative medicine. The development of non-immunogenic mRNA can be achieved through the use of modified nucleosides, which enhances safety and efficacy. By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription. Furthermore, effective delivery strategies tailored specifically for mRNA are crucial for the advancement of these therapies. The processes involved in loading and releasing mRNA from biomaterials are essential for their application in tissue restoration and require further refinement to maximize their potential.
"The transcription consumables segment accounted for the largest share by product segment in the mRNA synthesis and manufacturing market in 2023."
Based on product, the mRNA synthesis and manufacturing market is segmented into consumables, and instrument. In 2023, the consumables segment accounted for the largest share of mRNA synthesis and manufacturing market; this segment is further segmented into transcription consumables, purification consumables, and analysis & characterization consumables. Dominance of the consumables segment throughout the forecast period is attributed to the fact that they are essential for mRNA synthesis and manufacturing. Unlike instruments, which are a one-time investment, consumables must be replenished regularly, leading to continuous demand. Also, the entire market operates majorly on instruments offered by Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), whereas more companies operate in the consumables space for mRNA synthesis and manufacturing.
"The mRNA synthesis & modification service segment is expected to grow at the highest growth rate in the mRNA synthesis and manufacturing market throughout the forecast period."
Based on service, the mRNA synthesis and manufacturing market is segmented into mRNA synthesis & modification, mRNA purification, mRNA analysis & characterization, and manufacturing & scale-up. In 2023, the mRNA synthesis & modification segment accounted for the largest share of the mRNA synthesis and manufacturing market. A significant driver for the mRNA synthesis and modification services within the mRNA synthesis and manufacturing market is the growing need for customized mRNA sequences and modifications to enhance the efficacy and stability of therapeutic and vaccine candidates, which requires specialized synthesis and modification services. As the application of mRNA technology expands, researchers and developers increasingly seek tailored mRNA sequences that can be optimized for specific therapeutic outcomes, such as improved protein expression or enhanced immune response.
"The Asia Pacific region is growing at the highest CAGR in the mRNA synthesis and manufacturing market from 2024 to 2029."
The mRNA synthesis and manufacturing market is segmented into six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the fastest-growing regional segment in the global mRNA synthesis and manufacturing market, Factors such as rising healthcare expenditure; growing R&D expansion in key markets such as India, China, and Japan; low labor costs; and the favorable regulatory environment in the region are expected to contribute to market growth. China's mRNA synthesis and manufacturing market is driven by the country's substantial government investments in biotech innovation, rapid expansion of domestic biotech infrastructure, and increasing international collaborations. In recent developments, China has demonstrated a strong commitment to advancing mRNA technology.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20%
- By Designation: Directors - 50%, Managers - 30%, and Others - 20%
- By Region: North America -40%, Europe -35%, Asia-Pacific -20%, ROW -5%
List of Companies Profiled in the Report:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (US)
- GenScript (US)
- New England Biolabs (US)
- AldevronLLC. (Danaher Corporation) (US)
- Promega Corporation (US)
- Sartorius AG (Germany)
- WuXi Biologics (China)
- Takara Bio Inc. (Japan)
- GENEWIZ (Azenta USInc.) (US)
- TriLink BioTechnologies (US)
- Lonza (Switzerland)
- Telesis Bio Inc. (US)
- Aurigene Pharmaceutical Services Ltd. (Dr. Reddy's Laboratories Ltd.) (India)
- ST Pharm (South Korea)AGC Biologics (US)
Research Coverage:
This research report categorizes the mRNA synthesis and manufacturing market by Product (transcription consumables, purification consumables, analysis & characterization consumables, and instrument), Application (cell and gene therapy, vaccine, and other applications), End User (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, and acquisitions, and recent developments associated with the mRNA synthesis and manufacturing market. Competitive analysis of top players and upcoming startups in the mRNA synthesis and manufacturing market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mRNA synthesis and manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mrna technology, advancements in mrna synthesis technology, increased outsourcing for mrna synthesis and modification, and collaborations among industry players), restraints (High production cost, stringent regulations), opportunities (Advancements in drug delivery technologies, increased government funding and private investment, applications in regenerative medicines), and challenges (Stability, storage, and manufacturing scalability) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the mRNA synthesis and manufacturing market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the mRNA synthesis and manufacturing market
- Competitive Assessment: Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), GenScript (US), New England Biolabs (US), Aldevron, LLC. (Danaher Corporation) (US), Promega Corporation (US), Sartorius AG (Germany), WuXi Biologics (China), Takara Bio Inc. (Japan), GENEWIZ (Azenta US, Inc.) (US), TriLink BioTechnologies (US), Lonza (Switzerland), Telesis Bio Inc. (US), Aurigene Pharmaceutical Services Ltd. (Dr. Reddy's Laboratories Ltd.) (India), ST Pharm (South Korea), AGC Biologics (US), among others in the market.
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 STUDY SCOPE 32
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 33
1.3.2 INCLUSIONS AND EXCLUSIONS 34
1.3.3 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 34
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 38
2.2 MARKET SIZE ESTIMATION 39
2.2.1 GLOBAL MARKET SIZE ESTIMATION 40
2.2.2 INSIGHTS FROM PRIMARY SOURCES 43
2.2.3 TOP-DOWN APPROACH 43
2.3 GROWTH RATE PROJECTIONS 44
2.4 DATA TRIANGULATION 46
2.5 RESEARCH ASSUMPTIONS 47
2.6 RESEARCH LIMITATIONS 48
2.7 RISK ANALYSIS 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 54
4.1 MRNA SYNTHESIS & MANUFACTURING MARKET OVERVIEW 54
4.2 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PRODUCT AND COUNTRY, 2023 55
4.3 MRNA SYNTHESIS & MANUFACTURING SERVICES MARKET: GLOBAL
GROWTH OPPORTUNITIES 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
5.2.1 DRIVERS 57
5.2.1.1 Rise in clinical trials for mRNA vaccines 57
5.2.1.2 Continuous improvements in design, delivery systems, and manufacturing processes 58
5.2.1.3 Increased outsourcing of mRNA synthesis and production 59
5.2.1.4 Advantages of mRNA-based technology over recombinant expression 60
5.2.2 RESTRAINTS 60
5.2.2.1 High production cost 60
5.2.2.2 Stringent regulations 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Ongoing innovations in nanoparticles and cell-specific
delivery technologies 61
5.2.3.2 Expanding applications of mRNA technology 62
5.2.3.3 Increased government funding and private investments 63
5.2.4 CHALLENGES 64
5.2.4.1 Stability, storage, and manufacturing scalability issues 64
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65
5.4 REGULATORY LANDSCAPE 65
5.4.1 REGULATORY FRAMEWORK 65
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
5.5 VALUE CHAIN ANALYSIS 70
5.6 TECHNOLOGY ANALYSIS 71
5.6.1 KEY TECHNOLOGIES 71
5.6.1.1 In vitro transcription 71
5.6.1.2 Poly(A) tail synthesis 72
5.6.1.3 RNA stabilization technologies 72
5.6.2 COMPLEMENTARY TECHNOLOGIES 72
5.6.2.1 Next-generation sequencing 72
5.6.2.2 Gene cloning and vector construction 73
5.6.2.3 DNA amplification 73
5.6.3 ADJACENT TECHNOLOGIES 73
5.6.3.1 Spectrophotometry 73
5.6.3.2 Electrophoresis 74
5.6.3.3 High-performance liquid chromatography 74
5.7 PRICING ANALYSIS 74
5.7.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT 75
5.7.2 AVERAGE SELLING PRICE TREND FOR CONSUMABLES 75
5.7.3 AVERAGE SELLING PRICE, BY REGION 76
5.8 PATENT ANALYSIS 77
5.9 SUPPLY CHAIN ANALYSIS 78
5.10 ECOSYSTEM ANALYSIS 80
5.11 KEY CONFERENCES AND EVENTS, 2025-2026 83
5.12 PORTER'S FIVE FORCES ANALYSIS 84
5.12.1 INTENSITY OF COMPETITIVE RIVALRY 85
5.12.2 BARGAINING POWER OF SUPPLIERS 85
5.12.3 BARGAINING POWER OF BUYERS 85
5.12.4 THREAT OF SUBSTITUTES 85
5.12.5 THREAT OF NEW ENTRANTS 85
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 86
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 86
5.13.2 KEY BUYING CRITERIA, BY END USER (PRODUCT) 86
5.14 INVESTMENT AND FUNDING SCENARIO 87
5.15 IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET 88
6 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT 90
6.1 INTRODUCTION 91
6.2 CONSUMABLES 92
6.2.1 TRANSCRIPTION CONSUMABLES 94
6.2.1.1 mRNA synthesis kits 97
6.2.1.1.1 Increasing demand for rapid and efficient mRNA vaccine development to augment growth 97
6.2.1.2 mRNA profiling kits 99
6.2.1.2.1 Growing need for precision medicine and personalized therapies to propel market 99
6.2.1.3 RNA polymerases 101
6.2.1.3.1 Growing demand for high-quality and scalable mRNA production to boost market 101
6.2.1.4 Plasmid DNA/DNA templates 103
6.2.1.4.1 Rapid growth of mRNA-based therapeutics and vaccines to expedite growth 103
6.2.1.5 Nucleotides 105
6.2.1.5.1 Need to support diverse research & development initiatives to promote growth 105
6.2.1.6 Vectors 107
6.2.1.6.1 Need for reliable and high-capacity vectors to
propel market 107
6.2.1.7 Other transcription consumables 109
6.2.2 PURIFICATION CONSUMABLES 111
6.2.2.1 Purification kits & reagents 114
6.2.2.1.1 Rising focus on quality assurance to encourage growth 114
6.2.2.2 Chromatography filters & membranes 116
6.2.2.2.1 Growing emphasis on process optimization and cost-efficiency in large-scale production to drive market 116
6.2.2.3 Other purification consumables 118
6.2.3 ANALYSIS & CHARACTERIZATION CONSUMABLES 120
6.2.3.1 Analysis kits & reagents 122
6.2.3.1.1 Emerging applications of mRNA beyond vaccines to
support growth 122
6.2.3.2 Other analysis & characterization consumables 124
6.3 INSTRUMENTS 126
6.3.1 NEED TO REDUCE PRODUCTION COST AND HIGHER SCALABILITY TO PROMOTE GROWTH 126
7 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION 129
7.1 INTRODUCTION 130
7.2 CELL & GENE THERAPIES 130
7.2.1 RISING ADOPTION OF MRNA TECHNOLOGY TO TREAT GENETIC DISORDERS AND CANCER TO FUEL MARKET 130
7.3 VACCINES 132
7.3.1 INCREASING DEVELOPMENT AND DEPLOYMENT OF MRNA VACCINES TO ACCELERATE GROWTH 132
7.4 OTHER APPLICATIONS 134
8 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER 137
8.1 INTRODUCTION 138
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 138
8.2.1 NEED TO RESPOND TO EMERGING INFECTIOUS DISEASES TO DRIVE MARKET 138
8.3 ACADEMIC & RESEARCH INSTITUTIONS 141
8.3.1 INCREASING INVESTMENTS IN RESEARCH TO EXPEDITE GROWTH 141
8.4 CROS & CDMOS 143
8.4.1 RISING DEMAND FOR OUTSOURCED SERVICES TO AID GROWTH 143
9 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE 146
9.1 INTRODUCTION 147
9.2 MRNA SYNTHESIS & MODIFICATION SERVICES 147
9.2.1 GROWING NEED FOR CUSTOMIZED MRNA SEQUENCES AND
MODIFICATIONS TO FUEL MARKET 147
9.3 MRNA PURIFICATION SERVICES 149
9.3.1 NEED FOR PERSONALIZED MRNA VACCINES TO BOOST MARKET 149
9.4 MRNA ANALYSIS & CHARACTERIZATION SERVICES 151
9.4.1 INCREASING REGULATORY SCRUTINY TO EXPEDITE GROWTH 151
9.5 MANUFACTURING & SCALE-UP SERVICES 153
9.5.1 GROWING TRANSITION FROM SMALL-SCALE RESEARCH & DEVELOPMENT TO LARGE-SCALE COMMERCIAL PRODUCTION TO DRIVE MARKET 153
10 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER 156
10.1 INTRODUCTION 157
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 157
10.2.1 RAPID DEVELOPMENT AND COMMERCIALIZATION OF MRNA-BASED PRODUCTS TO ENCOURAGE GROWTH 157
10.3 ACADEMIC & RESEARCH INSTITUTIONS 160
10.3.1 INCREASING EMPHASIS ON TRANSLATING MRNA-BASED DISCOVERIES INTO PRACTICAL APPLICATIONS TO AID GROWTH 160
10.4 SMALL-SCALE CROS & CDMOS 162
10.4.1 NEED FOR SPECIALIZED AND FLEXIBLE PRODUCTION IN BIOTECH COMPANIES AND EARLY-STAGE MRNA PROJECTS TO BOOST MARKET 162
11 MRNA SYNTHESIS & MANUFACTURING MARKET, BY REGION 165
11.1 INTRODUCTION 166
11.2 NORTH AMERICA 167
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 171
11.2.2 US 172
11.2.2.1 Increasing demand for mRNA-based vaccines and therapeutics to accelerate growth 172
11.2.3 CANADA 176
11.2.3.1 Increasing collaborations between academic institutions and market players to spur growth 176
11.3 EUROPE 180
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 184
11.3.2 GERMANY 185
11.3.2.1 Growing establishment of manufacturing sites to boost market 185
11.3.3 UK 189
11.3.3.1 Presence of state-of-the-art facilities to support growth 189
11.3.4 FRANCE 192
11.3.4.1 Favorable government support for biopharmaceutical production to drive market 192
11.3.5 SWITZERLAND 196
11.3.5.1 Robust biotech sector and production facilities to promote growth 196
11.3.6 ITALY 199
11.3.6.1 Increasing collaborations among biotech firms and manufacturing facilities to aid growth 199
11.3.7 SPAIN 203
11.3.7.1 Growing investments in biotechnology to fuel market 203
11.3.8 REST OF EUROPE 206
11.4 ASIA PACIFIC 210
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 215
11.4.2 CHINA 215
11.4.2.1 Rapid expansion of domestic biotech sector to contribute to growth 215
11.4.3 JAPAN 219
11.4.3.1 Growing strategic investments in biotechnology infrastructure to boost market 219
11.4.4 INDIA 222
11.4.4.1 Booming biotech sector and international collaborations to
augment growth 222
11.4.5 SOUTH KOREA 226
11.4.5.1 Increased government funding in research and vaccine development to bolster growth 226
11.4.6 REST OF ASIA PACIFIC 229
11.5 LATIN AMERICA 233
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 237
11.5.2 BRAZIL 238
11.5.2.1 Increased funding for strengthening infrastructure to sustain growth 238
11.5.3 REST OF LATIN AMERICA 241
11.6 MIDDLE EAST 244
11.6.1 GROWING INVESTMENTS FROM PRIVATE SECTOR AND ACADEMIC RESEARCH INITIATIVES TO DRIVE MARKET 244
11.6.2 MACROECONOMIC OUTLOOK IN MIDDLE EAST 248
11.7 AFRICA 249
11.7.1 GROWING INITIATIVES TO ENHANCE LOCAL PRODUCTION CAPABILITIES TO PROPEL MARKET 249
11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 252
13 COMPANY PROFILES 277
13.1 KEY PLAYERS 277
13.1.1 THERMO FISHER SCIENTIFIC INC. 277
13.1.1.1 Business overview 277
13.1.1.2 Products/Services offered 278
13.1.1.3 Recent developments 280
13.1.1.3.1 Product/Service launches 280
13.1.1.3.2 Deals 280
13.1.1.3.3 Expansions 281
13.1.1.4 MnM view 281
13.1.1.4.1 Key strengths 281
13.1.1.4.2 Strategic choices 281
13.1.1.4.3 Weaknesses and competitive threats 281
13.1.2 DANAHER CORPORATION 282
13.1.2.1 Business overview 282
13.1.2.2 Products/Services offered 284
13.1.2.3 Recent developments 285
13.1.2.3.1 Product/Service launches 285
13.1.2.3.2 Deals 286
13.1.2.3.3 Expansions 286
13.1.2.4 MnM view 287
13.1.2.4.1 Key strengths 287
13.1.2.4.2 Strategic choices 287
13.1.2.4.3 Weaknesses and competitive threats 287
13.1.3 MERCK KGAA 288
13.1.3.1 Business overview 288
13.1.3.2 Products/Services offered 289
?
13.1.3.3 Recent developments 292
13.1.3.3.1 Deals 292
13.1.3.3.2 Expansions 293
13.1.3.4 MnM view 293
13.1.3.4.1 Key strengths 293
13.1.3.4.2 Strategic choices 293
13.1.3.4.3 Weaknesses and competitive threats 294
13.1.4 LONZA 295
13.1.4.1 Business overview 295
13.1.4.2 Products/Services offered 296
13.1.4.3 Recent developments 297
13.1.4.3.1 Deals 297
13.1.4.3.2 Expansions 298
13.1.4.4 MnM view 298
13.1.4.4.1 Key strengths 298
13.1.4.4.2 Strategic choices 298
13.1.4.4.3 Weaknesses and competitive threats 298
13.1.5 MARVAI LIFESCIENCES 299
13.1.5.1 Business overview 299
13.1.5.2 Products/Services offered 300
13.1.5.3 Recent developments 303
13.1.5.3.1 Product/Service launches 303
13.1.5.3.2 Deals 303
13.1.5.3.3 Expansions 304
13.1.5.4 MnM view 304
13.1.5.4.1 Key strengths 304
13.1.5.4.2 Strategic choices 304
13.1.5.4.3 Weaknesses and competitive threats 304
13.1.6 GENSCRIPT 305
13.1.6.1 Business overview 305
13.1.6.2 Products/Services offered 306
13.1.6.3 Recent developments 307
13.1.6.3.1 Product/Service launches 307
13.1.6.3.2 Deals 308
13.1.6.3.3 Expansions 308
13.1.6.4 MnM view 309
13.1.6.4.1 Key strengths 309
13.1.6.4.2 Strategic choices 309
13.1.6.4.3 Weaknesses and competitive threats 309
?
13.1.7 NEW ENGLAND BIOLABS 310
13.1.7.1 Business overview 310
13.1.7.2 Products/Services offered 310
13.1.7.3 Recent developments 311
13.1.7.3.1 Product/Service launches 311
13.1.8 PROMEGA CORPORATION 312
13.1.8.1 Business overview 312
13.1.8.2 Products/Services offered 312
13.1.8.3 Recent developments 313
13.1.8.3.1 Expansions 313
13.1.8.3.2 Other developments 313
13.1.9 WUXI BIOLOGICS 314
13.1.9.1 Business overview 314
13.1.9.2 Products/Services offered 315
13.1.9.3 Recent developments 316
13.1.9.3.1 Expansions 316
13.1.10 TAKARA BIO INC. 317
13.1.10.1 Business overview 317
13.1.10.2 Products/Services offered 318
13.1.10.3 Recent developments 319
13.1.10.3.1 Product/Service launches 319
13.1.10.3.2 Deals 319
13.1.11 SARTORIUS AG 320
13.1.11.1 Business overview 320
13.1.11.2 Products/Services offered 322
13.1.11.3 Recent developments 322
13.1.11.3.1 Deals 322
13.1.12 AZENTA US INC. 323
13.1.12.1 Business overview 323
13.1.12.2 Products/Services offered 324
13.1.13 TELESIS BIO INC. 325
13.1.13.1 Business overview 325
13.1.13.2 Products/Services offered 327
13.1.13.3 Recent developments 327
13.1.13.3.1 Product/Service launches 327
13.1.13.3.2 Deals 328
13.1.14 ST PHARM 329
13.1.14.1 Business overview 329
13.1.14.2 Products/Services offered 330
13.1.14.3 Recent developments 330
13.1.14.3.1 Deals 330
?
13.1.15 AGC INC. (THROUGH AGC BIOLOGICS) 331
13.1.15.1 Business overview 331
13.1.15.2 Products/Services offered 332
13.1.15.3 Recent developments 333
13.1.15.3.1 Deals 333
13.1.15.3.2 Expansions 333
13.1.16 DR. REDDY'S LABORATORIES LTD. 334
13.1.16.1 Business overview 334
13.1.16.2 Products/Services offered 335
13.1.16.3 Recent developments 336
13.1.16.3.1 Expansions 336
13.2 OTHER PLAYERS 337
13.2.1 ETHERNA 337
13.2.2 BOC SCIENCES 337
13.2.3 BIOMAY AG 338
13.2.4 CURIA GLOBAL, INC. 338
13.2.5 JENA BIOSCIENCE GMBH 339
13.2.6 ENZYNOMICS CO., LTD. 340
13.2.7 KANEKA EUROGENTEC S.A. 341
13.2.8 VERNAL BIOSCIENCES 341
13.2.9 CELLSCRIPT 342
14 APPENDIX 343
14.1 DISCUSSION GUIDE 343
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 347
14.3 CUSTOMIZATION OPTIONS 349
14.4 RELATED REPORTS 349
14.5 AUTHOR DETAILS 350
TABLE 1 MRNA SYNTHESIS & MANUFACTURING MARKET: INCLUSIONS AND EXCLUSIONS 34
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 46
TABLE 3 MRNA SYNTHESIS & MANUFACTURING MARKET: RISK ANALYSIS 48
TABLE 4 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT ANALYSIS OF
MARKET DYNAMICS 57
TABLE 5 INDICATIVE LIST OF MRNA VACCINES IN CLINICAL TRIALS (AS OF DECEMBER 2024) 58
TABLE 6 INDICATIVE LIST OF MRNA-BASED DRUGS IN CLINICAL TRIALS
(AS OF DECEMBER 2024) 62
TABLE 7 REGULATORY FRAMEWORK FOR MRNA SYNTHESIS &
MANUFACTURING MARKET WORLDWIDE 66
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 12 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT,
2021-2023 (USD) 75
TABLE 13 AVERAGE SELLING PRICE TREND FOR CONSUMABLES, 2021-2023 (USD) 75
TABLE 14 AVERAGE SELLING PRICE, BY REGION, 2023 (USD) 76
TABLE 15 MRNA SYNTHESIS & MANUFACTURING MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2024 78
TABLE 16 MRNA SYNTHESIS & MANUFACTURING MARKET: ROLE OF
COMPANIES IN ECOSYSTEM 82
TABLE 17 MRNA SYNTHESIS & MANUFACTURING MARKET: KEY CONFERENCES
AND EVENTS, 2025-2026 83
TABLE 18 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT OF
PORTER'S FIVE FORCES 84
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 86
TABLE 20 KEY BUYING CRITERIA, BY PRODUCT END USER 87
TABLE 21 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 91
TABLE 22 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 92
TABLE 23 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 93
TABLE 24 EUROPE: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 93
TABLE 25 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 93
TABLE 26 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 94
TABLE 27 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 94
TABLE 28 TRANSCRIPTION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 95
TABLE 29 TRANSCRIPTION CONSUMABLES MARKET, BY REGION,
2022-2029 (USD MILLION) 95
TABLE 30 NORTH AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 96
TABLE 31 EUROPE: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 96
TABLE 32 ASIA PACIFIC: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 96
TABLE 33 LATIN AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 97
TABLE 34 MRNA SYNTHESIS KITS MARKET, BY REGION, 2022-2029 (USD MILLION) 98
TABLE 35 NORTH AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 98
TABLE 36 EUROPE: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 98
TABLE 37 ASIA PACIFIC: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 99
TABLE 38 LATIN AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 99
TABLE 39 MRNA PROFILING KITS MARKET, BY REGION, 2022-2029 (USD MILLION) 100
TABLE 40 NORTH AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 100
TABLE 41 EUROPE: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 100
TABLE 42 ASIA PACIFIC: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 101
TABLE 43 LATIN AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 101
TABLE 44 RNA POLYMERASES MARKET, BY REGION, 2022-2029 (USD MILLION) 102
TABLE 45 NORTH AMERICA: RNA POLYMERASES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 102
TABLE 46 EUROPE: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 102
TABLE 47 ASIA PACIFIC: RNA POLYMERASES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 103
TABLE 48 LATIN AMERICA: RNA POLYMERASES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 103
TABLE 49 PLASMID DNA/DNA TEMPLATES MARKET, BY REGION, 2022-2029 (USD MILLION) 104
TABLE 50 NORTH AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 104
TABLE 51 EUROPE: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 104
TABLE 52 ASIA PACIFIC: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 105
TABLE 53 LATIN AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 105
TABLE 54 NUCLEOTIDES MARKET, BY REGION, 2022-2029 (USD MILLION) 106
TABLE 55 NORTH AMERICA: NUCLEOTIDES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 106
TABLE 56 EUROPE: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 106
TABLE 57 ASIA PACIFIC: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 107
TABLE 58 LATIN AMERICA: NUCLEOTIDES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 107
TABLE 59 VECTORS MARKET, BY REGION, 2022-2029 (USD MILLION) 108
TABLE 60 NORTH AMERICA: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 108
TABLE 61 EUROPE: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 108
TABLE 62 ASIA PACIFIC: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 63 LATIN AMERICA: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 64 OTHER TRANSCRIPTION CONSUMABLES MARKET, BY REGION,
2022-2029 (USD MILLION) 110
TABLE 65 NORTH AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 110
TABLE 66 EUROPE: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 110
TABLE 67 ASIA PACIFIC: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 111
TABLE 68 LATIN AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 111
TABLE 69 PURIFICATION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 112
TABLE 70 PURIFICATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 112
TABLE 71 NORTH AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 112
TABLE 72 EUROPE: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 113
TABLE 73 ASIA PACIFIC: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 113
TABLE 74 LATIN AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 113
TABLE 75 PURIFICATION KITS & REAGENTS MARKET, BY REGION,
2022-2029 (USD MILLION) 114
TABLE 76 NORTH AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 114
TABLE 77 EUROPE: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 115
TABLE 78 ASIA PACIFIC: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 115
TABLE 79 LATIN AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 115
TABLE 80 CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY REGION,
2022-2029 (USD MILLION) 116
TABLE 81 NORTH AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 82 EUROPE: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 117
TABLE 83 ASIA PACIFIC: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 117
TABLE 84 LATIN AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 117
TABLE 85 OTHER PURIFICATION CONSUMABLES MARKET, BY REGION,
2022-2029 (USD MILLION) 118
TABLE 86 NORTH AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 118
TABLE 87 EUROPE: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 119
TABLE 88 ASIA PACIFIC: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 119
TABLE 89 LATIN AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 119
TABLE 90 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 120
TABLE 91 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION,
2022-2029 (USD MILLION) 120
TABLE 92 NORTH AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 93 EUROPE: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 94 ASIA PACIFIC: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 95 LATIN AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 96 ANALYSIS KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 122
TABLE 97 NORTH AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 123
TABLE 98 EUROPE: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 123
TABLE 99 ASIA PACIFIC: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 123
TABLE 100 LATIN AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 124
TABLE 101 OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 124
TABLE 102 NORTH AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 103 EUROPE: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 104 ASIA PACIFIC: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 105 LATIN AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 106 MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 126
TABLE 107 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 127
TABLE 108 EUROPE: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 127
TABLE 109 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 127
TABLE 110 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 128
TABLE 111 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 130
TABLE 112 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY REGION, 2022-2029 (USD MILLION) 131
TABLE 113 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 114 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 115 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION) 132
TABLE 116 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION) 132
TABLE 117 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES,
BY REGION, 2022-2029 (USD MILLION) 133
TABLE 118 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION) 133
TABLE 119 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION) 133
TABLE 120 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 121 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 122 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 135
TABLE 123 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 135
TABLE 124 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 135
TABLE 125 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 136
TABLE 126 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 136
TABLE 127 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 138
TABLE 128 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 139
TABLE 129 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 139
TABLE 130 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 140
TABLE 131 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 140
TABLE 132 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 141
TABLE 133 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022-2029 (USD MILLION) 141
TABLE 134 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 135 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 136 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 137 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 143
TABLE 138 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION) 143
TABLE 139 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 140 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 141 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 142 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 145
TABLE 143 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 147
TABLE 144 MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 148
TABLE 145 NORTH AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 146 EUROPE: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 147 ASIA PACIFIC: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 148 LATIN AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 149 MRNA PURIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 150
TABLE 150 NORTH AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 150
TABLE 151 EUROPE: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 150
TABLE 152 ASIA PACIFIC: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 151
TABLE 153 LATIN AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 151
TABLE 154 MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 152
TABLE 155 NORTH AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 156 EUROPE: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 157 ASIA PACIFIC: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 158 LATIN AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 159 MANUFACTURING & SCALE-UP SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 154
TABLE 160 NORTH AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 154
TABLE 161 EUROPE: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 155
TABLE 162 ASIA PACIFIC: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 163 LATIN AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 164 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER,
2022-2029 (USD MILLION) 157
TABLE 165 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 158
TABLE 166 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 158
TABLE 167 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 159
TABLE 168 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 159
TABLE 169 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022-2029 (USD MILLION) 160
TABLE 170 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022-2029 (USD MILLION) 161
TABLE 171 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 172 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 173 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 162
TABLE 174 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION) 162
TABLE 175 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION) 163
TABLE 176 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 177 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 178 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 164
TABLE 179 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 164
TABLE 180 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY REGION,
2022-2029 (USD MILLION) 166
TABLE 181 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY REGION,
2022-2029 (USD MILLION) 166
TABLE 182 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 183 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 184 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 168
TABLE 185 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022-2029 (USD MILLION) 169
TABLE 186 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 169
TABLE 187 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 169
TABLE 188 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 170
TABLE 189 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 170
TABLE 190 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 170
TABLE 191 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION) 171
TABLE 192 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 171
TABLE 193 MACROECONOMIC INDICATORS FOR NORTH AMERICA 172
TABLE 194 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 173
TABLE 195 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES,
2022-2029 (USD MILLION) 173
TABLE 196 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 174
TABLE 197 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 174
TABLE 198 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 174
TABLE 199 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 175
TABLE 200 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 175
TABLE 201 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 175
TABLE 202 US: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 176
TABLE 203 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 176
TABLE 204 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 177
TABLE 205 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 177
TABLE 206 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 178
TABLE 207 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 178
TABLE 208 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 178
TABLE 209 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 179
TABLE 210 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 179
TABLE 211 CANADA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 179
TABLE 212 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 180
TABLE 213 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 181
TABLE 214 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 181
TABLE 215 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 181
TABLE 216 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 182
TABLE 217 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 182
TABLE 218 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 182
TABLE 219 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 183
TABLE 220 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 183
TABLE 221 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 183
TABLE 222 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 184
TABLE 223 MACROECONOMIC INDICATORS FOR EUROPE 185
TABLE 224 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 185
TABLE 225 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 186
TABLE 226 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 186
TABLE 227 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 187
TABLE 228 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 187
TABLE 229 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 187
TABLE 230 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 188
TABLE 231 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 188
TABLE 232 GERMANY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 188
TABLE 233 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 189
TABLE 234 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES,
2022-2029 (USD MILLION) 189
TABLE 235 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 190
TABLE 236 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 190
TABLE 237 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 190
TABLE 238 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 191
TABLE 239 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 191
TABLE 240 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 191
TABLE 241 UK: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 192
TABLE 242 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 192
TABLE 243 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 193
TABLE 244 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 193
TABLE 245 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 194
TABLE 246 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 194
TABLE 247 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 194
TABLE 248 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 195
TABLE 249 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 195
TABLE 250 FRANCE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 195
TABLE 251 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 196
TABLE 252 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022-2029 (USD MILLION) 196
TABLE 253 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 197
TABLE 254 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 197
TABLE 255 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 197
TABLE 256 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 198
TABLE 257 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 198
TABLE 258 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION) 198
TABLE 259 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 199
TABLE 260 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 199
TABLE 261 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES,
2022-2029 (USD MILLION) 200
TABLE 262 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 200
TABLE 263 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 201
TABLE 264 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 201
TABLE 265 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 201
TABLE 266 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 202
TABLE 267 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 202
TABLE 268 ITALY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 202
TABLE 269 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 203
TABLE 270 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 203
TABLE 271 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 204
TABLE 272 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 204
TABLE 273 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 204
TABLE 274 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 205
TABLE 275 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 205
TABLE 276 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 205
TABLE 277 SPAIN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 206
TABLE 278 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 206
TABLE 279 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022-2029 (USD MILLION) 207
TABLE 280 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 207
TABLE 281 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 208
TABLE 282 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 208
TABLE 283 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 208
TABLE 284 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 209
TABLE 285 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION) 209
TABLE 286 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 209
TABLE 287 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 211
TABLE 288 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 211
TABLE 289 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 211
TABLE 290 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 212
TABLE 291 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 212
TABLE 292 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 213
TABLE 293 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 213
TABLE 294 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 213
TABLE 295 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 214
TABLE 296 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 214
TABLE 297 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 214
TABLE 298 MACROECONOMIC INDICATORS FOR ASIA PACIFIC 215
TABLE 299 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 216
TABLE 300 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 216
TABLE 301 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 216
TABLE 302 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 217
TABLE 303 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 217
TABLE 304 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 217
TABLE 305 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 218
TABLE 306 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 218
TABLE 307 CHINA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 218
TABLE 308 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 219
TABLE 309 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 219
TABLE 310 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 220
TABLE 311 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 220
TABLE 312 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 221
TABLE 313 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 221
TABLE 314 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 221
TABLE 315 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 222
TABLE 316 JAPAN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 222
TABLE 317 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 223
TABLE 318 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES,
2022-2029 (USD MILLION) 223
TABLE 319 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 223
TABLE 320 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 224
TABLE 321 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 224
TABLE 322 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 224
TABLE 323 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 225
TABLE 324 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 225
TABLE 325 INDIA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 225
TABLE 326 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 226
TABLE 327 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022-2029 (USD MILLION) 226
TABLE 328 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 227
TABLE 329 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 227
TABLE 330 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 228
TABLE 331 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 228
TABLE 332 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 228
TABLE 333 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION) 229
TABLE 334 SOUTH KOREA: MRNA SYNTHESIS AND MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 229
TABLE 335 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 230
TABLE 336 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022-2029 (USD MILLION) 230
TABLE 337 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 231
TABLE 338 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 231
TABLE 339 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 231
TABLE 340 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 232
TABLE 341 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 232
TABLE 342 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD MILLION) 232
TABLE 343 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 233
TABLE 344 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 233
TABLE 345 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 234
TABLE 346 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 234
TABLE 347 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 234
TABLE 348 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 235
TABLE 349 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 235
TABLE 350 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 235
TABLE 351 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 236
TABLE 352 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 236
TABLE 353 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION) 236
TABLE 354 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 237
TABLE 355 MACROECONOMIC INDICATORS FOR LATIN AMERICA 237
TABLE 356 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 238
TABLE 357 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 238
TABLE 358 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 239
TABLE 359 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 239
TABLE 360 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 239
TABLE 361 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 240
TABLE 362 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 240
TABLE 363 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 240
TABLE 364 BRAZIL: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 241
TABLE 365 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 241
TABLE 366 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022-2029 (USD MILLION) 242
TABLE 367 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 242
TABLE 368 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 242
TABLE 369 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 243
TABLE 370 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 243
TABLE 371 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 243
TABLE 372 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD MILLION) 244
TABLE 373 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 244
TABLE 374 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 245
TABLE 375 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022-2029 (USD MILLION) 245
TABLE 376 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 246
TABLE 377 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 246
TABLE 378 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 246
TABLE 379 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 247
TABLE 380 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022-2029 (USD MILLION) 247
TABLE 381 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION) 247
TABLE 382 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022-2029 (USD MILLION) 248
TABLE 383 MACROECONOMIC INDICATORS FOR MIDDLE EAST 248
TABLE 384 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 249
TABLE 385 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION) 249
TABLE 386 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION) 250
TABLE 387 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION) 250
TABLE 388 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION) 250
TABLE 389 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 251
TABLE 390 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION) 251
TABLE 391 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD MILLION) 251
TABLE 392 AFRICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION) 252
TABLE 393 MACROECONOMIC INDICATORS FOR AFRICA 252
TABLE 406 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 277
TABLE 407 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 278
TABLE 408 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021-JANUARY 2025 280
TABLE 409 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-JANUARY 2025 280
TABLE 410 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-JANUARY 2025 281
TABLE 411 DANAHER CORPORATION: COMPANY OVERVIEW 282
TABLE 412 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 284
TABLE 413 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021-JANUARY 2025 285
TABLE 414 DANAHER CORPORATION: DEALS, JANUARY 2021-JANUARY 2025 286
TABLE 415 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-JANUARY 2025 286
TABLE 416 MERCK KGAA: COMPANY OVERVIEW 288
TABLE 417 MERCK KGAA: PRODUCTS/SERVICES OFFERED 289
TABLE 418 MERCK KGAA: DEALS, JANUARY 2021-JANUARY 2025 292
TABLE 419 MERCK KGAA: EXPANSIONS, JANUARY 2021-JANUARY 2025 293
TABLE 420 LONZA: COMPANY OVERVIEW 295
TABLE 421 LONZA: PRODUCTS/SERVICES OFFERED 296
TABLE 422 LONZA: DEALS, JANUARY 2021-JANUARY 2025 297
TABLE 423 LONZA: EXPANSIONS, JANUARY 2021-JANUARY 2025 298
TABLE 424 MARVAI LIFESCIENCES: COMPANY OVERVIEW 299
TABLE 425 MARVAI LIFESCIENCES: PRODUCTS/SERVICES OFFERED 300
TABLE 426 MARVAI LIFESCIENCES: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021-JANUARY 2025 303
TABLE 427 MARVAI LIFESCIENCE: DEALS, JANUARY 2021-JANUARY 2025 303
TABLE 428 MARVAI LIFESCIENCES: EXPANSIONS, JANUARY 2021-JANUARY 2025 304
TABLE 429 GENSCRIPT: COMPANY OVERVIEW 305
TABLE 430 GENSCRIPT: PRODUCTS/SERVICES OFFERED 306
TABLE 431 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025 307
TABLE 432 GENSCRIPT: DEALS, JANUARY 2021- JANUARY 2025 308
TABLE 433 GENSCRIPT: EXPANSIONS, JANUARY 2021-JANUARY 2025 308
TABLE 434 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 310
TABLE 435 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED 310
TABLE 436 NEW ENGLAND BIOLABS: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021-JANUARY 2025 311
TABLE 437 PROMEGA CORPORATION: COMPANY OVERVIEW 312
TABLE 438 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 312
TABLE 439 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021-JANUARY 2025 313
TABLE 440 PROMEGA CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2021-JANUARY 2025 313
TABLE 441 WUXI BIOLOGICS: COMPANY OVERVIEW 314
TABLE 442 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED 315
TABLE 443 WUXI BIOLOGICS: EXPANSIONS, JANUARY 2021-JANUARY 2025 316
TABLE 444 TAKARA BIO INC.: COMPANY OVERVIEW 317
TABLE 445 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 318
TABLE 446 TAKARA BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025 319
TABLE 447 TAKARA BIO INC.: DEALS, JANUARY 2021-JANUARY 2025 319
TABLE 448 SARTORIUS AG: COMPANY OVERVIEW 320
TABLE 449 SARTORIUS AG: PRODUCTS/SERVICES OFFERED 322
TABLE 450 SARTORIUS AG: DEALS, JANUARY 2021-JANUARY 2025 322
TABLE 451 AZENTA US INC.: COMPANY OVERVIEW 323
TABLE 452 AZENTA US INC.: PRODUCTS/SERVICES OFFERED 324
TABLE 453 TELESIS BIO INC.: COMPANY OVERVIEW 325
TABLE 454 TELESIS BIO INC.: PRODUCTS/SERVICES OFFERED 327
TABLE 455 TELESIS BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025 327
TABLE 456 TELESIS BIO INC.: DEALS, JANUARY 2021-JANUARY 2025 328
TABLE 457 ST PHARM: COMPANY OVERVIEW 329
TABLE 458 ST PHARM: PRODUCTS/SERVICES OFFERED 330
TABLE 459 ST PHARM: DEALS, JANUARY 2021-JANUARY 2025 330
TABLE 460 AGC INC.: COMPANY OVERVIEW 331
TABLE 461 AGC INC.: PRODUCTS/SERVICES OFFERED 332
TABLE 462 AGC INC.: DEALS, JANUARY 2021-JANUARY 2025 333
TABLE 463 AGC INC.: EXPANSIONS, JANUARY 2021-JANUARY 2025 333
TABLE 464 DR. REDDYS LABORATORIES LTD.: COMPANY OVERVIEW 334
TABLE 465 DR. REDDYS LABORATORIES LTD.: PRODUCTS/SERVICES OFFERED 335
TABLE 466 DR. REDDYS LABORATORIES LTD.: EXPANSIONS, JANUARY 2021-JANUARY 2025 336
TABLE 467 ETHERNA: COMPANY OVERVIEW 337
TABLE 468 BOC SCIENCES: COMPANY OVERVIEW 337
TABLE 469 BIOMAY AG: COMPANY OVERVIEW 338
TABLE 470 CURIA GLOBAL, INC.: COMPANY OVERVIEW 338
TABLE 471 JENA BIOSCIENCE GMBH: COMPANY OVERVIEW 339
TABLE 472 ENZYNOMICS CO., LTD.: COMPANY OVERVIEW 340
TABLE 473 KANEKA EUROGENTEC S.A.: COMPANY OVERVIEW 341
TABLE 474 VERNAL BIOSCIENCES: COMPANY OVERVIEW 341
TABLE 475 CELLSCRIPT: COMPANY OVERVIEW 342
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security